Biohaven Pharmaceutical Holding Company Ltd Stock, NYSE:BHVN
215 Church Street, New Haven, Connecticut 06510
Virgin Islands, British
Number of Employees: 825
Biohaven Pharmaceutical Holding Co. Ltd. is a clinical-stage biopharmaceutical company, which engages in the research and development of late-stage product candidates targeting neurological diseases, including rare disorders. It focuses on a pipeline of product candidates that represent mechanistic platforms, calcitonin gene-related peptide receptor antagonists, and glutamate modulators. The company was founded in September 2013 and is headquartered in New Haven, CT.